Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory

Psychopharmacology

Volumn 199, Issue 4, 2008, Pages 527-538

  Foley, John J ^a   Raffa, Robert B ^a   Walker, Ellen A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

5 Fluorouracil; Acquisition; Autoshaping operant; Chemotherapy; Cognition; Methotrexate; Methylscopolamine; Progressive ratio; Retention; Scopolamine

Indexed keywords

FLUOROURACIL; METHOTREXATE; METHYLSCOPOLAMINE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; INSTRUMENTAL CONDITIONING; LATENT PERIOD; LEARNING; MALE; MEMORY; MONOTHERAPY; MOUSE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; REINFORCEMENT; STATISTICAL ANALYSIS; SWISS WEBSTER MOUSE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CONDITIONING, OPERANT; DRUG INTERACTIONS; FLUOROURACIL; FOOD; INJECTIONS, INTRAPERITONEAL; LEARNING; MALE; MEMORY; METHOTREXATE; MICE; MOTIVATION; MUSCARINIC ANTAGONISTS; PIPERAZINES; REINFORCEMENT SCHEDULE; REWARD; SCOPOLAMINE; SEROTONIN AGONISTS;

EID: 48149092284     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-008-1175-y     Document Type: Article

References (59)

1. TA Ahles AJ Saykin 2002 Breast cancer chemotherapy-related cognitive dysfunction Clin Breast Cancer 3 Suppl 3 S84 S90
2. TA Ahles AJ Saykin 2007 Candidate mechanisms for chemotherapy-induced cognitive changes Nat Rev Cancer 7 192 201
3. Albritton RL, Coen DM, Golan DE (2005) Principles of combination chemotherapy. In: Golan DE, Tashjian AH, Armstrong EJ et al (eds) Principles of pharmacology, the pathophysiologic basis of drug therapy. Lippincott Williams & Wilkins, Philadelphia, PA, pp 603-613
4. Barrett JE, Vanover KE (2003) Assessment of learning and memory using the autoshaping of operant responding in mice. Current Protocols in Neuroscience. 8.5F.1-8.5F. Chapter 8
5. CB Brezden KA Phillips M Abdolell T Bunston IF Tannock 2000 Cognitive function in breast cancer patients receiving adjuvant chemotherapy J Clin Oncol 18 2695 701
6. BA Chabner MJ Ratain 2007 Clarification regarding "phase II trials published in 2002: a cross-specialty comparison showing significant design differences between oncology trials and other medical specialties" and the accompanying commentary, "phase II cancer trials: out of control?" Clin Cancer Res 13 6540
7. JR Coveney SB Sparber 1982 Phencyclidine retards autoshaping at a dose which does not suppress the required response Pharmacol Biochem Behav 16 937 942
8. JW Davenport 1974 Combined autoshaping-operant (AO) training: CS-UCS interval in rats Bulletin of the Psychomonic Society 3 383 385
9. Davis L, Lindley C (2005) Neoplastic disorders and their treatment: general principles. In: Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ (eds) Applied therapeutics: the clinical use of drugs. Lippincott, Williams & Wilkins, Philadelphia, pp 88-124
10. J Dietrich R Han Y Yang M Mayer-Proschel M Noble 2006 CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo J Biol 5 22.1 22.23
11. KA Donovan BJ Small MA Andrykowski FA Schmitt P Munster PB Jacobsen 2005 Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma Cancer 104 2499 507
12. M Gusella G Crepaldi C Barile A Bononi D Menon S Toso D Scapoli L Stievano E Ferrazzi F Grigoletto M Ferrari R Padrini 2006 Pharmacokinetic and demographic markers of 5-fluorouracil toxicity in 181 patients on adjuvant therapy for colorectal cancer Ann Oncol 17 1656 1660
13. K Hermelink M Untch MP Lux R Kreienberg T Beck I Bauerfeind K Munzel 2007 Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study Cancer 109 1905 1913
14. W Hodos 1961 Progressive ratio as a measure of reward strength Science 134 943 944
15. W Hodos G Kalman 1963 Effects of increment size and reinforcer volume on progressive ratio performance J Exp Anal Behav 6 387 392
16. M Inagaki E Yoshikawa Y Matsuoka Y Sugawara T Nakano T Akechi N Wada S Imoto K Murakami Y Uchitomi 2007 Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy Cancer 109 146 156
17. VA Jenkins DJ Bloomfield VM Shilling TL Edginton 2005 Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study BJU Int 96 48 53
18. Y Jin J Li LF Rong XW Lu Y Huang SY Xu 2005 Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice Acta Pharmacol Sin 26 250 256
19. GA Kennett G Curzon 1988 Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors Psychopharmacology (Berl) 96 93 100
20. GA Kennett MD Wood F Bright J Cilia DC Piper T Gager D Thomas GS Baxter IT Forbes P Ham TP Blackburn 1996 In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties Br J Pharmacol 117 427 434
21. A Kingma RI van Dommelen EL Mooyaart JT Wilmink BG Deelman WA Kamps 2001 Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only J Pediatr 139 413 420
22. J Kralovanszky C Katona A Jeney E Pandi P Noordhuis V Erdelyi-Toth L Otvos P Kovacs CL Van der Wilt GJ Peters 1999 5-Ethyl-2¢-deoxyuridine, a modulator of both antitumour action and pharmacokinetics of 5-fluorouracil J Cancer Res Clin Oncol 125 675 684
23. GD Lee DL Longo Y Wang JM Rifkind L Abdul-Raman JA Mamczarz KB Duffy EL Spangler DD Taub MP Mattson DK Ingram 2006 Transient improvement in cognitive function and synaptic plasticity in rats following cancer chemotherapy Clin Cancer Res 12 198 205
24. G Liy-Salmeron A Meneses 2007 Role of 5-HT1-7 receptors in short- and long-term memory for an autoshaping task: intrahippocampal manipulations Brain Res 1147 140 147
25. ED Lobo JP Balthasar 2003 Pharmacokinetic-pharmacodynamic modeling of methotrexate-induced toxicity in mice J Pharm Sci 92 1654 1664
26. JE Macleod JA DeLeo WF Hickey TA Ahles AJ Saykin DJ Bucci 2007 Cancer chemotherapy impairs contextual but not cue-specific fear memory Behav Brain Res 181 168 172
27. S Madhyastha SN Somayaji MS Rao K Nalini KL Bairy 2002 Hippocampal brain amines in methotrexate-induced learning and memory deficit Can J Physiol Pharmacol 80 1076 1084
28. LD Mayer AS Janoff 2007 Optimizing combination chemotherapy by controlling drug ratios Mol Interv 7 216 223
29. RG Mignone ET Weber 2006 Potent inhibition of cell proliferation in the hippocampal dentate gyrus of mice by the chemotherapeutic drug thioTEPA Brain Res 1111 26 29
30. PJ Mullenix WJ Kernan A Schunior A Howes DP Waber SE Sallan NJ Tarbell 1994 Interactions of steroid, methotrexate, and radiation determine neurotoxicity in an animal model to study therapy for childhood leukemia Pediatr Res 35 171 178
31. WR Mundy ET Iwamoto 1987 Studies on desglycinamide arginine vasopressin and scopolamine in a modified/lever-touch autoshaping model of learning/memory in rats Pharmacol Biochem Behav 27 307 315
32. S Ohdo K Inoue E Yukawa S Higuchi S Nakano N Ogawa 1997 Chronotoxicity of methotrexate in mice and its relation to circadian rhythm of DNA synthesis and pharmacokinetics Jpn J Pharmacol 75 283 290
33. A Ooi T Ohkubo M Higashigawa H Kawasaki H Kakito Y Kagawa M Kojima M Sakurai 2001 Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5¢-deoxy-5- fluorouridine Biol Pharm Bull 24 1329 1331
34. JA O'Shaughnessy 2002 Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy Clin Breast Cancer 3 Suppl 3 S116 S120
35. GJ Peters JH Schornagel GA Milano 1993 Clinical pharmacokinetics of anti-metabolites Cancer Surv 17 123 156
36. AB Reiriz GK Reolon T Preissler JO Rosado JA Henriques R Roesler G Schwartsmann 2006 Cancer chemotherapy and cognitive function in rodent models: memory impairment induced by cyclophosphamide in mice Clin Cancer Res 12 5000 author reply 5000-1
37. NR Richardson DC Roberts 1996 Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy J Neurosci Methods 66 1 11
38. MA Richmond BP Nichols RM Deacon JN Rawlins 1997 Effects of scopolamine and hippocampal lesions on negative patterning discrimination performance in rats Behav Neurosci 111 1217 1227
39. AJ Saykin HA Wishart 2003 Mild cognitive impairment: conceptual issues and structural and functional brain correlates Semin Clin Neuropsychiatry 8 12 30
40. AJ Saykin HA Wishart LA Rabin RB Santulli LA Flashman JD West TL McHugh AC Mamourian 2006 Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI Neurology 67 834 842
41. SB Schagen FS van Dam MJ Muller W Boogerd J Lindeboom PF Bruning 1999 Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma Cancer 85 640 650
42. SB Schagen HL Hamburger MJ Muller W Boogerd FS van Dam 2001 Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function J Neurooncol 51 159 165
43. SB Schagen MJ Muller W Boogerd RM Rosenbrand D van Rhijn S Rodenhuis FS van Dam 2002 Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients Ann Oncol 13 1387 1397
44. SB Schagen MJ Muller W Boogerd FS Van Dam 2002 Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective Clin Breast Cancer 3 Suppl 3 S100 S108
45. SB Schagen MJ Muller W Boogerd GJ Mellenbergh FS van Dam 2006 Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients J Natl Cancer Inst 98 1742 1745
46. R Seigers SB Schagen W Beerling W Boogerd O van Tellingen FS van Dam JM Koolhaas B Buwalda 2008 Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat Behav Brain Res 186 168 175
47. HE Shannon EL Eberle 2006 Effects of biasing the location of stimulus presentation, and the muscarinic cholinergic receptor antagonist scopolamine, on performance of a 5-choice serial reaction time attention task in rats Behav Pharmacol 17 71 85
48. PM Silberfarb D Philibert PM Levine 1980 Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients Am J Psychiatry 137 597 601
49. DH Silverman CJ Dy SA Castellon J Lai BS Pio L Abraham K Waddell L Petersen ME Phelps PA Ganz 2007 Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy Breast Cancer Res Treat 103 303 311
50. D Stafford MG LeSage JR Glowa 1998 Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review Psychopharmacology (Berl) 139 169 184
51. SM Stemmer JC Stears BS Burton RB Jones JH Simon 1994 White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support AJNR Am J Neuroradiol 15 1267 1273
52. HS Stock RA Rosellini GC Abrahamsen RJ McCaffrey JC Ruckdeschel 1995 Methotrexate does not interfere with an appetitive Pavlovian conditioning task in Sprague-Dawley rats Physiol Behav 58 969 973
53. N Tchen HG Juffs FP Downie QL Yi H Hu I Chemerynsky M Clemons M Crump PE Goss D Warr ME Tweedale IF Tannock 2003 Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer J Clin Oncol 21 4175 4183
54. FS van Dam SB Schagen MJ Muller W Boogerd E vd Wall ME Droogleever Fortuyn S Rodenhuis 1998 Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy J Natl Cancer Inst 90 210 218
55. KE Vanover JE Barrett 1998 An automated learning and memory model in mice: pharmacological and behavioral evaluation of an autoshaped response Behav Pharmacol 9 273 283
56. SJ Ward TW Lefever C Jackson RJ Tallarida EA Walker 2008 Effects of a CB1 receptor antagonist and 5-HT2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice J Pharmacol Exp Ther 325 567 576
57. MH Wieneke ER Dienst 1995 Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer Psychooncology 4 61 66
58. G Winocur J Vardy MA Binns L Kerr I Tannock 2006 The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice Pharmacol Biochem Behav 85 66 75
59. JA Yanovski RJ Packer JD Levine TL Davidson M Micalizzi G D'Angio 1989 An animal model to detect the neuropsychological toxicity of anticancer agents Med Pediatr Oncol 17 216 221